[2] Spillane JB,Henderson MA. Cancer stem cells:a review[J]. ANZ J Surg,2007,77(6):464-468. |
[2]
|
Jemal A,Bray F,Center MM,et al. Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90. |
[3] Ping YF,Bian XW. Consice review:contribution of cancer stem cells to neovascularization[J]. Stem Cells,2011,29 ( 6 ):888-894. |
[4] 谭小宇,戴东,刘国华. 动态检测 CA-153、VEGF-A 探讨乳腺癌预后的相关性研究[J]. 中国实验诊断学,2009,13(6):901-903. |
[5] Kumda T,Tsuneyama K,Hatta H,et al. Improved 1-h rapid immunostaining method using intermitten microwave irradiation:practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital [J]. Mod Pathol,2004,17(9):1141-1149. |
[6] 武世伍,承泽农,俞岚,等. CD82/KAI1 和 HIF-1 在非小细胞肺癌中的表达及其与血管生成拟态的关系[J]. 中国肺癌杂志,2011,14(12):918-925. |
[7] O'Brien CA,Pollett A,Gallinger S,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J]. Nature,2007,445(7123):106-110. |
[8] Janikova M,Skarda J,Dziechciarkova M,et al. Identification of CD133 + /Nestin + putative cancer stem cells in non-small cell lung cancer[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2010,154(4):321-326. |
[9] Zhao P,Li Y,Lu Y. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma[J]. BMC Cancer,2010,10:218. |
[10] Ferrandina G,Bonanno G,Pierelli L,et al. Expression of CD133-1 and CD133-2 in ovarian cancer[J]. Int J Gynecol Cancer,2008,18(3):506-514. |
[11] Wu S,Yu L,Wang D,et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry[J]. BMC Cancer,2012,12:535. |
[12] Xu YH,Zhang GB,Wang JM,et al. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis[J]. Saudi Med J,2010,31(9):980-986. |
[13] Mineo TC,Ambrogi V,Baldi A,et al. Prognostic impact of VEGF,CD31,CD34 and CD105 expression and tumor vessel invasion after radical surgery for IB-IIA non-small cell lung cancer[J]. J Clin Pathol,2004,57(6):591-597. |
[14] 甄乐锋,叶长生,刘民锋,等. D2-40 和 CD34 在乳腺浸润性导管癌中的表达及其意义[J]. 南方医科大学学报,2010,30(7):1548-1551. |
[15] Schneider M,Huber J,Hadaschik B,et al. Characterization of colon cancer cells:a functional approach characterizing CD133 as a potential stem cell marker[J]. BMC Cancer,2012,12:96. |
[16] Hilbe W,Dirnhofer S,Oberwasserlechner F,et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer[J]. J Clin Pathol,2004,57 (9):965-969. |